Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates
出版年份 2021 全文链接
标题
Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates
作者
关键词
-
出版物
Microbiology Spectrum
Volume 9, Issue 1, Pages -
出版商
American Society for Microbiology
发表日期
2021-07-28
DOI
10.1128/spectrum.00585-21
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy of Ceftolozane/Tazobactam in combination with Colistin against Extensively drug-resistant Pseudomonas aeruginosa including High Risk Clones in an In Vitro Pharmacodynamic Model
- (2020) María Montero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Battle Is on: New Beta-Lactams for the Treatment of Multidrug-Resistant Gram-Negative Organisms
- (2020) Mandee Noval et al. Current Infectious Disease Reports
- Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of Pseudomonas aeruginosa
- (2020) Emel Mataraci Kara et al. Infectious Diseases
- Activity of aztreonam in combination with ceftazidime–avibactam against serine- and metallo-β-lactamase–producing Pseudomonas aeruginosa
- (2020) Michelle Lee et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model
- (2019) Joan Gómez-Junyent et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Analysis of the susceptibility to ceftazidime/avibactam in German MDR/XDR Pseudomonas aeruginosa comparing different methods
- (2019) Frieder Schaumburg et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant (XDR) Pseudomonas aeruginosa, including high-risk clones
- (2019) María M. Montero et al. Journal of Global Antimicrobial Resistance
- Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa
- (2019) Sandra Mikhail et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Selecting the dosage of ceftazidime–avibactam in the perfect storm of nosocomial pneumonia
- (2019) Shampa Das et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Resistance to Ceftazidime-Avibactam and Underlying Mechanisms
- (2019) Yuhang Wang et al. Journal of Global Antimicrobial Resistance
- Evaluation of Ceftolozane-Tazobactam in Combination with Meropenem against Pseudomonas aeruginosa Sequence Type 175 in a Hollow-Fiber Infection Model
- (2018) M. Montero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015
- (2018) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates
- (2017) Paolo Gaibani et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Activity of colistin alone or in combination with rifampicin or meropenem in a carbapenem-resistant bioluminescent Pseudomonas aeruginosa intraperitoneal murine infection model
- (2017) Yun Cai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa
- (2017) Pablo A Fraile-Ribot et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria
- (2017) Mark D. Gonzalez et al. Annals of Laboratory Medicine
- Assessment of early combination effects of colistin and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii in dynamic time-kill experiments
- (2017) Thomas Tängdén et al. Infectious Diseases
- Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate
- (2016) Juan P. Horcajada et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In VitroPharmacodynamics of Various Antibiotics in Combination against Extensively Drug-Resistant Klebsiella pneumoniae
- (2015) Tze-Peng Lim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
- (2015) Romney M. Humphries et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Distinctive Binding of Avibactam to Penicillin-Binding Proteins of Gram-Negative and Gram-Positive Bacteria
- (2015) Abdelhamid Asli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The increasing threat of Pseudomonas aeruginosa high-risk clones
- (2015) Antonio Oliver et al. DRUG RESISTANCE UPDATES
- Unexpected Challenges in Treating Multidrug-Resistant Gram-Negative Bacteria: Resistance to Ceftazidime-Avibactam in Archived Isolates of Pseudomonas aeruginosa
- (2014) Marisa L. Winkler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen
- (2014) Etienne de Montmollin et al. INTENSIVE CARE MEDICINE
- Systematic Review and Meta-Analysis ofIn VitroSynergy of Polymyxins and Carbapenems
- (2013) Oren Zusman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study
- (2013) Luisa Sorlí et al. BMC INFECTIOUS DISEASES
- Characterization of -lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104)
- (2012) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Creeping baselines and adaptive resistance to antibiotics
- (2011) Lucía Fernández et al. DRUG RESISTANCE UPDATES
- A Novel Approach to Pharmacodynamic Assessment of Antimicrobial Agents: New Insights to Dosing Regimen Design
- (2011) Vincent H. Tam et al. PLoS Computational Biology
- The Combination of Meropenem and Levofloxacin Is Synergistic with Respect to both Pseudomonas aeruginosa Kill Rate and Resistance Suppression
- (2010) A. Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
- (2009) D. Plachouras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections
- (2009) M. Montero et al. INFECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search